Peter M.  Neupert net worth and biography

Peter Neupert Biography and Net Worth

Director of Labcorp
Peter M. Neupert has served as a director of the Company since January 1, 2013. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Neupert served on the President’s Information Technology Advisory Committee (PITAC), co-chairing the Health Information Technology Subcommittee and helping to drive the “Revolutionizing Health Care Through Information Technology” report, published in June 2004. Mr. Neupert served as the founding President and Chief Executive Officer of drugstore.com from 1998 to 2001 and as Chairman of the board of directors through September 2004. Mr. Neupert has served as a director of Adaptive Biotechnologies Corporation since December 2013 and currently serves as the Lead Independent Director. He served on the Board of Directors of Quality Systems, Inc., now known as NextGen Healthcare, Inc., from August 2013 to January 2014. He previously served as a trustee for the Fred Hutchinson Cancer Research Center and was an active member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2007 to 2011. Mr. Neupert brings to the Board experience as a recognized expert in health information technology and perspective on how to grow shareholder value leveraging business strategies with technology. Mr. Neupert is an audit committee financial expert as a result of his experience, including his experience as CEO and Chairman of drugstore.com. Mr. Neupert serves as the Board’s lead independent director.

What is Peter M. Neupert's net worth?

The estimated net worth of Peter M. Neupert is at least $17.16 million as of August 8th, 2025. Mr. Neupert owns 65,632 shares of Labcorp stock worth more than $17,157,517 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Neupert may own. Learn More about Peter M. Neupert's net worth.

How do I contact Peter M. Neupert?

The corporate mailing address for Mr. Neupert and other Labcorp executives is 358 South Main Street, BURLINGTON NC, 27215. Labcorp can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Peter M. Neupert's contact information.

Has Peter M. Neupert been buying or selling shares of Labcorp?

Peter M. Neupert has not been actively trading shares of Labcorp in the last ninety days. Most recently, on Wednesday, February 16th, Peter M. Neupert bought 3,500 shares of Labcorp stock. The stock was acquired at an average cost of $263.66 per share, with a total value of $922,810.00. Learn More on Peter M. Neupert's trading history.

Who are Labcorp's active insiders?

Labcorp's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Richelle Parham (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Labcorp's active insiders.

Are insiders buying or selling shares of Labcorp?

During the last year, insiders at the medical research company sold shares 19 times. They sold a total of 54,892 shares worth more than $14,048,330.71. The most recent insider tranaction occured on November, 11th when CEO Adam H Schechter sold 5,745 shares worth more than $1,509,498.75. Insiders at Labcorp own 0.8% of the company. Learn More about insider trades at Labcorp.

Information on this page was last updated on 11/11/2025.

Peter M. Neupert Insider Trading History at Labcorp

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2022Buy3,500$263.66$922,810.00View SEC Filing Icon  
See Full Table

Peter M. Neupert Buying and Selling Activity at Labcorp

This chart shows Peter M Neupert's buying and selling at Labcorp by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Labcorp Company Overview

Labcorp logo
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Read More

Today's Range

Now: $261.42
Low: $259.42
High: $265.56

50 Day Range

MA: $269.95
Low: $245.96
High: $291.34

2 Week Range

Now: $261.42
Low: $209.38
High: $293.72

Volume

861,158 shs

Average Volume

928,922 shs

Market Capitalization

$21.67 billion

P/E Ratio

25.68

Dividend Yield

1.08%

Beta

0.99